Leprosy Susceptibility To 4 C1970254
Genetic variation that may increase susceptibility to leprosy, a chronic bacterial infection primarily affecting skin and peripheral nerves.
Key facts at a glance
- ICD-10
- R69
- ICD-11
- MA00.0
- Body system
- immunologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(immunologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Patchy loss of skin pigmentation
(integumentary)Decreased temperature sensation in limbs
(neurologic)Atrophy of small hand muscles
(musculoskeletal)Recurrent skin ulcerations
(integumentary)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Contact tracing and screening
Systematic screening of household contacts and close associates for early signs of leprosy, along with periodic follow-up examinations in endemic area residents.
Exercise prescription and weight management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Environmental risk reduction
Strategies to reduce exposure risk including improving living conditions, ventilation, and avoiding prolonged close contact with untreated leprosy patients in endemic settings.
When to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Leprosy Susceptibility To 4 C1970254?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
World Health Organization Leprosy Guidelines Committee. Guidelines for the diagnosis, treatment and prevention of leprosy. Int J Lepr Other Mycobact Dis. 2022.
Scollard DM, Truman RW, Butlin CR. Leprosy: Epidemiology, microbiology, clinical manifestations, and diagnosis. Lancet Infect Dis. 2021.
Geluk A, van Meijgaarden KE, Wilson L. Immunological biomarkers for leprosy susceptibility: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2020.
Martins AC, Miranda A, Oliveira ML. Genetic susceptibility factors in leprosy: A case-control study in Brazilian population. BMC Infect Dis. 2019.
Medication Comparisons
Compare medications used to treat Leprosy Susceptibility To 4 C1970254. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy